Financhill
Back

Medpace Holdings Quote, Financials, Valuation and Earnings

Medpace Holdings Price Quote

$393.47
+6.95 (+1.8%)
(Updated: February 22, 2024 at 5:55 PM ET)

Medpace Holdings Key Stats

Buy
68
Medpace Holdings (MEDP) is a Buy

Day range:
$377.31 - $387.04
52-week range:
$167.00 - $399.41
Dividend yield:
0%
P/E ratio:
43.53
P/S ratio:
6.52
P/B ratio:
21.27%

Volume:
228.8K
Avg. volume:
247.3K
1-year change:
94.33%
Market cap:
$11.9B
Revenue:
$1.9B
EPS:
$8.88

How Much Does Medpace Holdings Make?

Is Medpace Holdings Growing As A Company?

  • What Is Medpace Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.26%
  • What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.16%

Medpace Holdings Stock Price Performance

  • Did Medpace Holdings Stock Go Up Last Month?
    Medpace Holdings share price went up by 30.71% last month
  • Did MEDP's Share Price Rise Over The Last Year?
    MEDP share price rose by 94.33% over the past 1 year

What Is Medpace Holdings 52-Week High & Low?

Medpace Holdings Price To Free Cash Flow

Is It Risky To Buy Medpace Holdings?

  • How Much Debt Does Medpace Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Medpace Holdings Have?
    Cash and short term investments quarterly total is $245.4M
  • What Is Medpace Holdings’s Book Value Per Share?
    Book value per share is 18.18

Is Medpace Holdings Cash Flow Positive?

  • What Is MEDP Cash Flow From Operations?
    Cash flow from operations (TTM) is $433.4M
  • What Is Medpace Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$182.6M
  • What Is Medpace Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$34.6M

Medpace Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    MEDP return on invested capital is 59.55%
  • What Is Medpace Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 19.37%
  • What Is MEDP Return On Equity?
    ROE is a measure of profitability and is 65.63%

Medpace Holdings Earnings Date & Stock Price

Medpace Holdings Competitors

  • Who Are Medpace Holdings's Competitors?
    Below is a list of companies who compete with Medpace Holdings or are related in some way:
    • Avid Bioservices Inc (CDMO)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Renovaro Inc (RENB)
    • Sarepta Therapeutics Inc (SRPT)
    • ShockWave Medical Inc (SWAV)

Medpace Holdings Dividend Yield

Data Unavailable

Medpace Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 16.04% -1.78%
Revenue: 26.47% 0.13%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 1
Price Target: 382.80
Downside from Last Price: -0.96%

Major Shareholders

  • How many MEDP shares are owned by institutional investors?
    290.1M MEDP shares are owned by institutional investors
  • How many MEDP shares are owned by insiders?
    870.6K MEDP shares are owned by insiders